For decades, inhibitors of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel have been used as tools to investigate the role and function of CFTR conductance in cystic fibrosis research. In the early 2000s, two new and potent inhibitors of CFTR, CFTRinh-172 and GlyH-101, were described and are now widely used to inhibit specifically CFTR. However, despite some evidence, the effects of both drugs on other types of Cl − -conductance have been overlooked. In this context, we explore the specificity and the cellular toxicity of both inhibitors in CFTR-expressing and non-CFTR-expressing cells.
Introduction
The cystic fibrosis transmembrane conductance regulator (CFTR) is a glycoprotein expressed at the apical membrane of airway, gastrointestinal, renal and other epithelial cells, mutations of which cause the genetic disease cystic fibrosis. The CFTR is a cAMP-dependent Cl − channel, but it also modulates other ion channels and transporters (Julien et al., 1999; Barriere et al., 2003; L'Hoste et al., 2009; Billet and Hanrahan, 2013 ; channel nomenclature follows Alexander et al., 2013) . CFTR dysfunction alters ion and fluid secretions in several organs and produces cystic fibrosis with lung disease, intestinal obstruction, pancreatic insufficiency and male infertility.
In the late 1980s, several patch-clamp studies described a Cl − channel exhibiting low conductance (<10 pS) and activated by increased intracellular cAMP level (Gray et al., 1988; Champigny et al., 1990; Tabcharani et al., 1990) . Soon after, studies using the patch-clamp technique confirmed the ability of the protein CFTR to transport, selectively, Cl − ions (Drumm et al., 1990; Rich et al., 1990) . Since this important discovery, investigations of the role, function and structure/ activity relationship of the CFTR Cl − channel have concentrated on the discovery of selective inhibitors. After a screening of 200 compounds, Greger and colleagues identified two very potent inhibitors of CFTR-like Cl − permeable conductances in kidney cells: diphenylamine-2-carboxylate (DPC; Di Stefano et al., 1985) and 5-nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB; Wangemann et al., 1986) . However, the specificity and efficacy of these inhibitors were highly dependent on the concentrations used and inhibited not only the CFTR conductance, but also other types of Cl − conductances such as the volume-sensitive outwardly rectifying Cl − conductance (VSORC), the calciumactivated Cl − conductance (CaCC) or even members of the ClC family, such as ClC-2 (Furukawa et al., 1998) and CLC-3 (Wang et al., 2012) . For more than a decade, these two inhibitors and other compounds such as glibenclamide, were routinely used to study the Cl − selective CFTR channel (see Hwang and Sheppard, 1999) .
In 2002, Verkman and colleagues identified the thiazolidinones as a new family of compounds that were able to inhibit more specifically CFTR in the micromolar range (Ma et al., 2002) . Among these, phenyl]-5-[(4-carboxyphenyl)methylene]-2-thioxo-4-thiazolidinone) was identified as the most potent and most specific reversible inhibitor for three CFTR-related functions: the epithelial iodide transport; the cellular Cl − current; and the secretion of intestinal fluid. CFTRinh-172 acts as an allosteric inhibitor, targeting the cytoplasmic face of the CFTR protein at its nucleotide-binding domain 1 and maintaining a closed state of the related Cl − conductance. This inhibitor exhibited an IC50 around 300 nM that could rise to µM levels, in epithelial cells .
The same group identified glycine hydrazides as another class of CFTR inhibitors (Muanprasat et al., 2004) . N -(2 -naphthalenyl) -((3,5 -dibromo -2,4 -dihydroxyphenyl) methylene)glycine hydrazide (GlyH-101), the most potent compound of this class, occludes the channel pore from the extracellular side, causes a voltage-dependent inhibition of CFTR current and transforms the CFTR-related linear currentvoltage relationship in an inwardly rectifying curve when applied at 10 µM, with Ki values from 1.4 µM at +60 mV to 5.6 µM at −60 mV (Muanprasat et al., 2004) . This inhibitor was defined as an open-channel blocker of CFTR and was more water-soluble than CFTRinh-172 (∼1 mM for GlyH-101 and only 20-50 µM for CFTRinh-172) making it a better tool for further pharmacological investigations of the CFTR (Barman et al., 2011; Stahl et al., 2012; Fisher et al., 2013; Rubera et al., 2013) .
The effectiveness, in vivo, of both CFTR inh-172 and a derivative of GlyH-101 was established through their inhibition of cholera toxin-induced intestinal fluid secretion (Thiagarajah et al., 2004) and of CFTR-dependent cyst growth in a mouse model of autosomal dominant polycystic kidney disease (Yang et al., 2008) . They are now widely used in cystic fibrosis research to investigate in detail the role of CFTR in various cell types and/or organs (Sondo et al., 2011; Lu and Ding, 2012) .
However, the wide range of concentrations used, varying from 20 µM (Bijvelds et al., 2009) up to 100 µM (Baniak et al., 2012) for CFTRinh-172 and from 20 µM (Illek et al., 2008) up to 50 µM (Zhang et al., 2010; Muanprasat et al., 2013) for GlyH-101, give rise to many concerns about specificity and the 'appropriate concentrations to use' for these compounds. Therefore, we conducted a study to test the efficacy (concentration-dependency) and specificity of these widely used CFTR inhibitors on various types of Cl − currents already identified and described in different cell lines (Barriere et al., 2003; l'Hoste et al., 2010) . Briefly, the putative inhibitory effect of both inhibitors on the ubiquitous VSORC conductance was tested in CFTR-expressing cells (kidney cell line), as well as in non-CFTR-expressing cells (PS120 cell line). We also explored the effect of CFTRinh-172 and GlyH-101 on the CaCC conductance in the kidney cell model.
Using the patch-clamp technique, we first confirmed that these two compounds are potent inhibitors of the CFTRmediated Cl − conductance. However, we also found that GlyH-101 inhibited two other Cl − -conductance types (VSORC and CaCC) at almost the same concentration as that used to inhibit CFTR, raising concerns about its ability to selectively inhibit the CFTR-mediated conductance in a multicomponent Cl − channel biological system. CFTRinh-172 was similarly lacking in specificity, as we observed inhibition of VSORCmediated conductance with this compound when used in concentrations greater than 5 µM. We finally tested the cellular toxicity of these inhibitors. We discuss the implication of these finding for studies of the pathophysiology of CFTR channels.
Methods

Culture of kidney cells
For the CFTR-expressing cell model, we used immortalized cell lines of murine renal distal convoluted tubules (DCT) or proximal convoluted tubules (PCT) (Barriere et al., 2003; Milosavljevic et al., 2010; Peyronnet et al., 2012) . For the non-CFTR-expressing cells, we used PS120 cell line (a cell line derived from hamster CCL39 fibroblasts) lacking the cftr gene (Barriere et al., 2001; Milosavljevic et al., 2010) . Cultures were maintained in a water-saturated atmosphere of 5% CO2/95% air at 37°C. and cell capacitances were recorded using an EPC 10 amplifier [HEKA Elektronik, Lambrecht (Pfalz) , Germany]. Cells were held at −40 mV, and 400 ms pulses from −100 to +100, +120 or +140 mV were applied in 20 mV increments. I/V relationships were expressed as mean current amplitudes measured at all potentials at 50 or 350 ms after the pulse onset. The offset potentials between both electrodes were zeroed before sealing and corrected for liquid junction potentials as previously described (Duranton et al., 2002) .
The 
Cell viability/cytotoxicity assay kit
The LIVE/DEAD ® Cell Viability/Cytotoxicity Assay Kit (Invitrogen, Saint-Aubin, France) was used on cells after 24 h of incubation with CFTR inhibitors, cultured with 1% serum. Using this kit, living cells showed green fluorescence (detecting calcein-acetoxymethyl ester) and dead cells showed red fluorescence (detecting homodimeric ethidium bromide). Cells were visualized with a Carl Zeiss Axiovert D1 inverted microscope using a 40× LD Plan-Neofluar objective (Carl Zeiss SAS, LE Peck, France). Images were recorded using an Axiocam MRm (Carl Zeiss SAS), and quantification of green and red fluorescence was performed using individual pixel quantification with ImageJ software (NIH, Bethesda, MD, USA) on three independent micrographs per well.
MTT assays
The MTT assay is based on the transformation of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide in formazan by mitochondrial dehydrogenase allowing estimation of cell viability. Cells cultured in a 48-well plate (1% serum) and exposed for 24 h to CFTR inhibitors, were rinsed once with PBS and incubated for 1 h (37°C, 5% CO2) into a DMEM:F12 culture medium without phenol red, supplemented with 5% serum and 0.5 mg mL −1 of MTT. Cells were then lysed (SDS 10%, HCl 0.01N) and maintained overnight in the same condition. Optical density measurements were performed at 562 nm, using a Biotek microplate reader. Lysates of eight independent conditions were prepared and two MTT assays were performed for each condition.
Data analysis
Statistical analysis was performed using R software (R Development Core Team (2011). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http:// www.R-project.org/). Dose-response relationships for each experimental condition were fitted with the Hill equation using SigmaPlot software (Systat Software, San Jose, CA, USA) to calculate IC50 values. P < 0.05 was accepted to show significant differences between means.
Materials
All chemical compounds were provided by Sigma Aldrich except for GlyH-101 compound (Merck Millipore Darmstadt, Germany).
Results
To study the effects of CFTRinh-172 and GlyH-101 on cell viability and the putative inhibitory effect of both substances on three different chloride channel types, we used CFTRexpressing cells (epithelial kidney cells originating from proximal or distal convoluted segments, PCT or DCT) and non-CFTR-expressing cells (PS120 cells). In these kidney cell models, a CFTR-mediated conductance, a VSORC and a CaCC have been described in detail, previously (Barriere et al., 2003; L'Hoste et al., 2009) .
Cellular toxicity of the CFTR inh -172 and GlyH-101 inhibitors on CFTR-expressing and non-CFTR-expressing cells
We first evaluated the cytotoxicity of CFTRinh-172 and GlyH-101 in kidney cells. Confluent cell cultures were exposed to increasing concentrations of GlyH-101 and CFTRinh-172 (1-50 µM), and the fluorescent dye assay used to determine cytotoxicity (live/dead labelling) after incubation for 24 h. Figure 1A illustrates confluent cell monolayers in the absence and presence of CFTRinh-172 (upper part) or GlyH-101 (lower part). From 1 to 20 µM, CFTRinh-172 and GlyH-101 had no significant effect on cell viability as indicated by a homogeneous green labeling of the monolayers ( Figure 1A and B). However at a higher concentration (50 µM), both substances induced cell death as revealed by the decrease of greenlabelled areas and a simultaneous increase in red positive cells (dead cells). To confirm the toxicity of both substances, we performed MTT assays on confluent CFTR-expressing cells monolayers. These experiments confirmed for both substances a dramatic decrease of the cell viability at 50 µM but revealed also a marked effect for lower concentrations (20 µM and even 10 µM, Figure 1C ). MTT assays were also performed on non-CFTR-expressing PS120 cells. GlyH-101 also decreased cell viability ( Figure 1D ) at concentrations higher than 5 µM. Interestingly, CFTRinh-172 was more cytotoxic than GlyH-101 and exhibited a significant effect at 5 µM.
Specificity and efficacy of CFTR inh -172 and GlyH-101 inhibitors on CFTR-like conductances
To record only the CFTR-like Cl − conductance in the CFTRexpressing cell model, the endogenous CaCC-mediated current was impaired by the use of a high concentration of EGTA in the pipette solution and the extracellular bath solution was adjusted to 320 mosmol kg −1 H2O (addition of mannitol) to avoid activation of the VSORC conductance (Barriere et al., 2003) . Under these experimental conditions, perfusion of forskolin (1-10 µM) rapidly induced (<4 min) the activation of a Cl − current exhibiting a linear current/voltage relationship (Figure 2A-C) . Once the forskolin-activated current had reached a maximum, CFTRinh-172 or GlyH-101 were per-fused at increasing concentrations (0.5, 1, 5, 10 µM, Figure 2A and B). CFTRinh-172 induced a reversible concentrationdependent inhibition of the CFTR-like current that was maximal at 5 µM (Figure 2A and D) . Similarly, GlyH-101 induced a concentration-dependent inhibition of the CFTRlike current ( Figure 2B and E). This inhibition was partly reversible on washing the cells (70% of recovery within 4 min) and showed a significant potential dependency (at 10 µM, the inhibition was more pronounced at positive potentials than at negative potentials, Figure 2B , C and E). Figure 2D and E summarises the inhibition for each concentration of the inhibitors. Values are expressed as a function of CFTR-maximal current slope (current slopes were calculated between −100 and −60 mV and between +60 and +100 mV). The concentration-response curve revealed an IC50 value below 1µM for CFTRinh-172 (0.74 and 0.56 µM for negative and positive potentials respectively) and varying between 3 µM at negative potentials and 0.87 µM at positive potentials for GlyH101. These results confirmed the ability of both drugs to inhibit efficiently the CFTR-mediated Cl − currents in mouse kidney cells.
Sensitivity of the VSORC to CFTR inh -172 and GlyH-101 inhibitors
Next we looked for the effects of CFTRinh-172 and GlyH-101 inhibitors on the VSORC in CFTR-expressing and non-CFTRexpressing cells. As expected, exposing both cell models to a hypo-osmotic shock (through a decrease of external osmotic pressure from 320-330 to 290 mosmol kg −1 H2O) induced outwardly rectifying currents exhibiting a time-dependent inactivation at depolarizing potentials ( Figure 3A and B). Once this activated conductance was stable, cells were exposed to increasing concentrations of CFTRinh-172 ( Figure 3A and B) . In CFTR-expressing cells, CFTRinh-172 did not affect this conductance up to 1 µM but, at 10 µM, partly and reversibly inhibited the VSORC ( Figure 3A and C, ∼50% of inhibition at negative and positive potentials). The non-specific inhibitor of Cl − conductance NPPB (100 µM) completely inhibited the remaining fraction of the VSORC current. Similarly in non-CFTR-expressing cells, CFTRinh-172 inhibited also the VSORC current in a concentration-dependent manner ( Figure 3B and D). Figure 3E and F illustrates the percentage of inhibition of the VSORC conductance for increasing concentrations of CFTRinh-172 measured at negative (from −100 to −60 mV, Figure 3E ) and positive potentials (from +60 to +100 mV, Figure 3F ), in CFTR-expressing and non-CFTR-expressing cells. In CFTR-expressing cells, CFTRinh-172 exhibited an IC50 of 12 µM towards VSORC-mediated Cl − currents either at negative or positive potentials. In non-CFTR-expressing cells, the calculated IC50 was 5.33 µM, independent of applied potential.
Similar experiments were performed on the VSORC conductance using the GlyH-101 inhibitor. As shown in Figure 4A and B, in CFTR-expressing cells, GlyH-101 was a very potent and reversible inhibitor of the VSORC conductance and exhibited a greater efficacy than CFTRinh-172, with significant inhibition at 0.5 µM and almost total blockade at 10 µM ( Figure 4A and B) . The IC50 was calculated to be about 1 µM (0.87 and 1.07 µM for negative and positive potentials, respectively) and suggested an inhibitory effect independent of the membrane potential ( Figure 4E and F) . In non-CFTR-expressing cells, GlyH-101 also inhibited the VSORC current ( Figure 4C and D) with an IC50 of 5.38 and 6.26 µM at negative and positive potentials respectively ( Figure 4E and F) . Altogether, the inhibition of VSORC conductance by CFTRinh-172 and GlyH-101 in both cell models suggested a direct action of both compounds on the channel pore.
Sensitivity of the CaCC to CFTR inh -172 and GlyH-101 inhibitors
Next, we evaluated the inhibitory effects of CFTRinh-172 and GlyH-101 on the CaCC in the two cell models. As already demonstrated in CFTR-expressing cells (Barriere et al., 2003) , ionomycin (2 µM) stimulated an outwardly rectifying Cl − conductance exhibiting a time-dependent activation at depolarizing potentials (Figure 5A-C ). Once the current had reached a maximum (3-6 min), cells were exposed to increasing concentrations of CFTRinh-172 ( Figure 5A ) and GlyH-101 ( Figure 5B ). CFTRinh-172 did not affect the CaCC up to 10 µM ( Figure 5A, C and D) . Interestingly, GlyH-101 was without effect at the lowest concentration (0.5 µM, not shown), but significantly reduced Ca 2+ -activated Cl − current at higher concentrations ( Figure 5B, C and D) . When applied at 10 µM, GlyH-101 blocked more than 70% (n = 5) of the CaCC conductance (slope current calculated between +60 and +100 mV, Figure 5D ). The concentration-response curve revealed an IC50 of 3.38 µM for positive potentials.
Discussion and conclusion
In this study we have evaluated the putative inhibitory effects of two CFTR inhibitors (CFTRinh-172 and GlyH-101) on three well-described Cl − -mediated conductances: CFTR, the volume-activated Cl − conductance (VSORC) and the CaCC. As expected, both inhibitors totally inhibited the forskolinactivated CFTR Cl − conductance with an IC50 in the micromolar range. GlyH-101 induced a specific profile of inhibition of the CFTR-mediated conductance with a more pronounced inhibition at positive potentials than at negative potentials. However, the inward rectification induced by 5 or 10 µM of GlyH-101 was much less pronounced than previously demonstrated (Muanprasat et al., 2004) . This minor difference might be partially explained by a difference in the sensitivity and biophysical properties between mouse CFTR and human CFTR (Muanprasat et al., 2004) .
Besides the inhibition of CFTR conductance, we also demonstrated that GlyH-101 inhibited two other types of Cl − conductances (VSORC and CaCC) at concentrations close to those used to inhibit CFTR conductance. We also observed a significant inhibition of CaCC at low concentrations of GlyH-101 which was in agreement with an earlier report that GlyH-101 inhibited ionomycin-induced I − fluxes driven by TMEM16A protein [the main constituent of the CaCC ]. This inhibition reached more than 60% with 20 µM of GlyH-101. This sensitivity of the CaCC to GlyH-101 was also reported at a higher concentration (50 µM) in cells expressing human CFTR (Muanprasat et al., 2004) . The other non-CFTR conductance examined, VSORCwas also inhibited (Figure 4 ) at low concentrations of GlyH-101 with an almost complete inhibition of the current at 10 µM. The use of non-CFTR-expressing cells demonstrated the direct action of GlyH-101 on the VSORC. This is an important finding as a link between CFTR expression and VSORC activity in several cell lines has already been demonstrated (Vennekens et al., 1999; Ando-Akatsuka et al., 2002) . Taken together, the demonstration that GlyH-101 inhibits VSORC and CaCC at almost the same concentrations
Figure 3
Effects of CFTRinh-172 on the VSORC measured in CFTR-expressing cells (kidney) and in non-CFTR-expressing cells (PS120). (A and B) Whole-cell currents recorded in CFTR-expressing cells (A) and in non-CFTR-expressing cells (B). Cl − currents were recorded in control conditions and after replacing the hypertonic bath by a hypotonic solution (hypo). Once the Cl − conductance is fully developed (3-4 min), CFTRinh-172 was perfused (5, 10 µM as indicated). Normal bath solution was made hypertonic (340 mOsmol including 30-40 mOsm of Mannitol), and the hypotonic one was adjusted by removing mannitol from the normal bath solution (290 mOsm). NPPB (100 µM) completely inhibited swelling-activated Cl Effects of GlyH-101 on VSORC conductance measured in CFTR-expressing cells (kidney) and in non-CFTR-expressing cells (PS120). (A and C) Whole-cell current traces recorded in CFTR-expressing cells (A) and in non-CFTR-expressing cells (C) in control condition and after replacing the hypertonic bath by a hypotonic solution (hypo). Once the Cl − conductance is fully developed, GlyH-101 was perfused at increasing concentrations (0.5, 1, 5, 10 µM) as indicated. The membrane potential was held at −40 mV and currents were elicited by a train of 11 voltage steps (400 ms duration) between −100 and +100 mV in +20 mV increments. (5-10 µM) as used to fully inhibit CFTR, raises serious questions about its specificity and excludes this compound from future investigations as a means of clearly distinguishing CFTR-mediated conductance in a multicomponent Cl − channel conductance analysis.
Concerning CFTRinh-172, we noted that a concentration of 5 µM induced a full inhibition of the CFTR conductance along with no noticeable inhibition of the CaCC [as previously observed ] but a noticeable, but moderate, inhibition (from ∼15 to 50% depending on the cell Values measured for each concentration were individually normalized to the maximal current slope measured between +60 and +120 mV in the absence of any inhibitor. Values are means (±SEM) of five to six individual cells. *P < 0.05, Tukey's HSD test. The insets show the logarithmic dose-response curve for GlyH-101 and calculated between −100 and −60 mV (E) and between +60 and +120 mV (F).
type) of the VSORC. We conclude that, low concentrations of CFTRinh-172 (<10 µM) might represent the best experimental condition to provide fully inhibition of the CFTR conductance, with minimum effects on other Cl − conductances. Figure 6 summarises the concentration ranges of CFTRinh-172 and GlyH-101 used by us and their corresponding effects on CFTR, VSORC and CaCC conductances, expressed in mouse kidney epithelial cells.
Our data obtained on the efficacy of CFTRinh-172 and GlyH-101 apply only to mouse models, as a recent study (Stahl et al., 2012) using different CFTR orthologs, originating from human, killifish, pig and shark, disclosed a marked species-related difference in sensitivity to CFTRinh-172. For example, in the oocyte expression system, the shark 'CFTRlike' protein was almost insensitive to CFTRinh-172 (10% of inhibition at 25 µM) while the human CFTR was only inhibited by ∼50% at 20 µM. Therefore, we could surmise the inhibitory effects of CFTRinh-172 and GlyH-101 would also be different between the different orthologues of the proteins supporting the CaCC (mainly members of the TMEM16 family) and the VSORC conductances.
Besides the effects of both inhibitors on CFTR and non-CFTR Cl − conductances, CFTRinh-172 and GlyH-101 also impaired mitochondrial function in cell lines, devoid of CFTR (Kelly et al., 2010) . These authors demonstrated that CFTRinh-172 and GlyH-101 induced, within 30 min, a significant increase in the production of reactive oxygen species, starting at a low concentration, 0.2 µM, for both inhibitors and correlated with a fall in the mitochondrial membrane potential. However, in spite of this evidence for impaired mitochondrial function, this effect does not seem to be related to short term toxicity, as both compounds were cytotoxic only at high concentration (∼50 µM, Figure 1) . Nevertheless, this nonspecific effect raises important concerns for the potential therapeutic applications of these compounds.
Finally, for CFTR inh-172, a concentration of 5 µM is probably the best to fully and selectively inhibit CFTR conductance, without affecting other type of Cl − conductances (i.e. VSORC and the CaCC) or cell viability. In conclusion, investigators should be wary of the non-selectivity of GlyH-101 (and to a lesser extent, of CFTRinh-172) in order not to falsely attribute effects only to inhibition of CFTR.
